Statistical analysis methods for QT/QTc prolongation

Journal of Biopharmaceutical Statistics

Volumn 18, Issue 3, 2008, Pages 553-563

  Ma, Haijun ^a   Smith, Brian ^a   Dmitrienko, Alex ^b  

^a Eli Lilly and Company ^*

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Cardiac repolarization; QT prolongation; QTc correction; QTc interval; Thorough QT QTc study

Indexed keywords

ANALYTIC METHOD; ARTICLE; DRUG INDUSTRY; DRUG RESEARCH; ELECTROCARDIOGRAM; HEART RATE; METHODOLOGY; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SIMULATION; STATISTICAL ANALYSIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; HUMAN; INTERNATIONAL COOPERATION; LONG QT SYNDROME; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICAL MODEL; STATISTICS;

DATA INTERPRETATION, STATISTICAL; DRUG INDUSTRY; ELECTROCARDIOGRAPHY; GUIDELINES AS TOPIC; HEART RATE; HUMANS; INTERNATIONAL COOPERATION; LONG QT SYNDROME; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 45849085419     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400801995494     Document Type: Article

References (17)

1. Batchvarov, V. N., Ghuran, A., Smetana, P., Hnatkova, K., Herries, M., Dilaveris, P., Camm, A. J., Malik, M. (2002). QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. American Journal of Physiology - Heart Circulatory Physiology 282:H2356-H2363.
2. Bazett, H. C. (1920). An analysis of time relation of electrocardiograms. Heart 20:174-195.
3. Diggle, P. J., Heagerty, P. J., Liang, K. Y., Zeger, S. L. (2002). Analysis of Longitudinal Data. 2nd ed. Oxford University Press.
4. Dmitrienko, A., Smith, B. (2002). Analysis of the QT interval in clinical trials. Drug Information Journal 36:269-279.
5. Dmitrienko, A., Smith, B. (2003). Repeated-measures models in the analysis of QT interval. Pharmaceutical Statistics 2:175-190.
6. Dmitrienko, A., Sides, G., Winters, K., Kovacs, R., Eisenberg, P., Groh, W. (2005). Electrocardiogram reference ranges derived from a standardized clinical trial population. Drug Information Journal 39:395-406.
7. Fitzmaurice, G., Laird, N., Ware, J. (2004). Applied Longitudinal Analysis. John Wiley and Sons.
8. Galeazzi, R. L., Benet, L. Z., Sheiner, L. B. (1976). Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clinical Pharmacology and Therapeutics 20:278-289.
9. ICH. (2004). Step 1 Draft 4 Preliminary Concept Paper. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs.
10. Li, L., Desai, M., Desta, Z., Flockhart, D. (2004). QT analysis: A complex answer to a "simple" problem. Statistics in Medicine 23:2625-2643.
11. Littell, R. C., Milliken, G. A., Stroup, W. W., Wolfinger, R. D. (1996). SAS System for Mixed Models. SAS Publishing.
12. Malik, M. (2001). Problems of heart rate corrections in assessment of drug-induced QT interval prolongation. Journal of Cardiovascular Electrophysiology 12:411-412.
13. Malik, M., Farbom, P., Batchvarov, V., Hnatkova, K., Camm, A. J. (2002). Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval. Heart 87:220-228.
14. Pinheiro, J. C., Bates, D. M. (2000). Mixed-Effects Models in S and S-PLUS. Berlin: Springer-Verlag.
15. Sagie, A., Larson, M. G., Goldberg, R. J., Bengtson, J. R., Levy, D. (1992). An improved method for adjusting the QT interval for heart rate (The Framingham Heart Study). American Journal of Cardiology 70:797-801.
16. Shah, R. R. (2005). Drugs, QT interval prolongation and ICH E14: The need to get it right. Drug Safety 28:115-125.
17. Shah, A., Hajian, G. (2003). A maximum likelihood approach for estimating the QT correction factor using mixed effects model. Statistics in Medicine 22:1901-1909.